Celldex develops antibody drugs for mast cell driven and other inflammatory, allergic and autoimmune diseases. It last closed at $28.04 on Nov 17, down 1.92% on the day. The average 12-month price target from 5 analysts is $70.60 (+151.8% from the last close), with a high of $88.00 and a low of $61.00. Analyst consensus is Strong Buy, based on the latest ratings from 5 firms (5 buy, 0 hold, 0 sell). Over the past 90 days StreetAlpha recorded 2 whale options trades in CLDX, 100% of them bullish and 0% bearish. In the past 30 days there were 1 dark pool print totaling $500K, the largest $500K.
Each firm's latest rating on CLDX in the past 90 days
Average 12-month target
$70.60
▲ 151.8% upside
Based on 5 analysts who set a price target on CLDX in the past 90 days. The average target is $70.60, with a high of $88.00 and a low of $61.00, compared with the last close of $28.04.
Low $61.00Avg $70.60High $88.00
Blue marker: last close $28.04
Highest target$88.00
Average target$70.60
Lowest target$61.00
Latest rating changes
Canaccord GenuityTarget raised
Nov 9Buy$60 → $68
Morgan StanleyTarget raised
Nov 9Buy$57 → $61
Leerink PartnersMaintained
Sep 23Buy$88
Morgan StanleyTarget raised
Sep 23Buy$50 → $57
HC Wainwright & Co.Target raised
Sep 22Buy$42 → $64
Date
Firm
Action
Rating
Price target
Nov 9
Canaccord Genuity
Target raised
Buy
$60 → $68
Nov 9
Morgan Stanley
Target raised
Buy
$57 → $61
Sep 23
Leerink Partners
Maintained
Buy
$88
Sep 23
Morgan Stanley
Target raised
Buy
$50 → $57
Sep 22
HC Wainwright & Co.
Target raised
Buy
$42 → $64
Loading…
Technical Analysis
CLDX · as of the Nov 17 close · updated after every close
Downtrend
The stock is 5% below its 20 day and 12% below its 50 day average. It is 17% below its 200 day average, so the longer trend is down. Momentum is neutral (RSI 40). The nearest support is the swing low (Nov 6) at $27.82, and the nearest resistance the Pivot at $28.28.
Short trendBearish
Long trendBearish
MomentumNeutral
StretchNormal
VolatilityNormal, 5.1%/day
Key levels
$45.1452 week high+61.0%
$35.31100 day average+25.9%
$32.88200 day average+17.3%
$31.5450 day average+12.5%
$30.40Swing high (Oct 27)+8.4%
$29.4920 day average+5.2%
$29.06Pivot R1+3.6%
$28.28Pivot+0.9%
$28.04Last close
$27.82Swing low (Nov 6)−0.8%
$27.26Pivot S1−2.8%
$22.3352 week low−20.4%
Indicators
RSI (14)
40.34
Middle of its range
Neutral
MACD
-0.68
Above its signal line
Bullish
Stochastic
19.8
Near the bottom of its range
Oversold
ADX (14)
20.8
Weak trend
Williams %R
-87.0
Oversold below −80, overbought above −20
Oversold
CCI (20)
-145.4
Oversold below −100, overbought above 100
Oversold
Rate of change
−5.6%
Change over 10 sessions
Bearish
ATR (14)
$1.43
Typical daily range, 5.1% of price
MA 10Below
MA 20Below
MA 50Below
MA 100Below
MA 200Below
Falling
Short trendBearish
Long trendNot enough history
MomentumWeak
StretchNormal
VolatilityNormal, 12.2%/day
Key levels
$45.1452 week high+61.0%
$35.31100 day average+25.9%
$32.88200 day average+17.3%
$31.5450 day average+12.5%
$30.40Swing high (Oct 27)+8.4%
$29.4920 day average+5.2%
$29.06Pivot R1+3.6%
$28.28Pivot+0.9%
$28.04Last close
$27.82Swing low (Nov 6)−0.8%
$27.26Pivot S1−2.8%
$22.3352 week low−20.4%
Indicators
RSI (14)
39.84
Weak, oversold below 30
Neutral
MACD
-1.21
Below its signal line
Bearish
Stochastic
8.3
Near the bottom of its range
Oversold
ADX (14)
20.7
Weak trend
Williams %R
-96.4
Oversold below −80, overbought above −20
Oversold
CCI (20)
-101.8
Oversold below −100, overbought above 100
Oversold
Rate of change
−24.0%
Change over 10 sessions
Bearish
ATR (14)
$3.41
Typical daily range, 12.2% of price
MA 10Below
MA 20Below
MA 50Below
MA 100Above
MA 200–
What happened before, for CLDX
Signal name goes hereSince a recent date
9 times
+0.0%
Signal name goes hereSince a recent date
9 times
+0.0%
Signal name goes hereSince a recent date
9 times
+0.0%
What happened before
See how CLDX did after each of today's signals in the past: how often it was higher 10 sessions later, and the typical move, next to its usual record.
November seasonalityHow CLDX usually does this month. See Seasonality
Calculated from daily prices after each close. Signals describe the chart, not where the stock will go. Past patterns often fail. Not investment advice.
Seasonality
How CLDX has done in each calendar month: the average and median return, how often each month finished higher, and every year since 2006.
From SEC Form 13F filings for Sep 30, 2026. What the filings show, not a forecast: positions can be up to 45 days old and leave out short sales.
AI Auto Pilots
Paper trading
StreetAlpha runs four autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether CLDX is in one of them and how their past CLDX trades turned out.
Celldex is a biopharmaceutical company based in Hampton, New Jersey. It develops antibody drugs aimed at diseases driven by mast cells, including chronic urticaria, prurigo nodularis and atopic dermatitis, as well as other severe inflammatory, allergic and autoimmune conditions. Its main candidates are barzolvolimab, a monoclonal antibody, and a bispecific antibody platform for new inflammatory targets. The company has not yet sold any drugs commercially and is focused on patients whose current treatment options are inadequate.